Micronutrient malnutrition, characterized by insufficient intake levels of vitamins and minerals, is a major public health problem that affects about 2 billion people worldwide. In order to reduce the burden of this 'hidden hunger', biofortification is more and more advocated as an alternative to the current micronutrient interventions. Through the enhancement of the micronutrient level of staple crops, it could address micronutrient malnutrition where the need is highest. Because staple crops are characterized by low micronutrient concentrations, genetic breeding techniques are often applied to increase specific vitamin levels, such as folate and pro-vitamin A. This study sheds a light on the global status of micronutrient malnutrition, biofortification and GM biofortified rice as both a GM food product with health benefits and a micronutrient intervention. Thereby, key consumer preference studies and cost-effectiveness analyses on Folate Biofortified Rice and Golden Rice are presented. Support is found for GM biofortified rice as a well-accepted GM food crop and a highly cost-effective health intervention.
I. Introduction
Within the scope of crop improvement, biofortification of rice is more and more advocated as a tool to improve human nutrition. By enhancing the micronutrient level of the worlds' most consumed staple crop, micronutrient malnutrition could be addressed where the need is highest. As rice varieties are mainly characterized by a low vitamin and mineral content, agricultural biotechnology is applied to increase specific micronutrient levels in rice, such as folate and pro-vitamin A (beta-carotene). This chapter describes the history and trends in biofortification and GM rice with health benefits in particular. In spite of the potential consumer benefits of this new generation of GM crops, the use of biotechnology in food products remains controversial. As none of these crops are available at the marketplace, they
were subject of various ex-ante evaluation studies in order to examine the consumer demand, the potential health benefits and the cost-effectiveness of their introduction. By reviewing the current state-of-the-art, this study sheds a light on the potential of GM biofortified rice as both a GM food product with health benefits and an alternative policy intervention to tackle micronutrient deficiencies.
As a starting point, the global burden of micronutrient malnutrition and the main micronutrient deficiencies is described (section II). In the following two sections, (GM) biofortification is described within the framework of health interventions to address micronutrient malnutrition (section III) and within the scope of agricultural crop improvement (section IV). Next, the global status of the development and commercialization of (GM) biofortified crops and GM rice (section V) as well as GM biofortified rice (section VI) is presented. While the section IV looks at the amount of published research on GM food, GM rice, biofortification and Golden Rice, section VIII and IX summarize the key research findings on the consumer preferences for, and the potential cost-effectiveness of GM biofortified rice. These two research topics are crucial to ex-ante evaluate micronutrient interventions and GM foods. Finally, some key challenges (section X) and conclusions are formulated (section XI).
II.

What is at stake? The global burden of micronutrient malnutrition
Micronutrient malnutrition a 1 is defined by a chronic lack of micronutrients, i.e. essential vitamins and minerals that are needed in small quantities, and has a large impact on global health and (indirectly) hinders social and economic prosperity, e.g. through productivity losses, cognitive impairment and soaring health care costs 2, 3 . Malnutrition is considered one of the principal causes of morbidity and mortality among the poor 4 .
Most people are not aware of their lack of micronutrients, due to the subclinical character of such deficiencies, and because the underlying causes and health functions of different micronutrients are neglected, poorly addressed, or still undiscovered. Therefore, this form of malnutrition is often referred to as the 'hidden hunger'. Insufficient intake of micronutrients reflects a lack of dietary quality and especially strikes poor people living in rural, less developed areas, because these populations are largely dependent on staple crops (e.g. rice, maize and wheat), which are known to contain little micronutrients [2] [3] [4] [5] . As a consequence, multiple micronutrient deficiency is the rule rather than the exception. Half of malnourished children, for instance, are deficient on several vital micronutrients 5 .
a There is a clear difference between under-and malnutrition in that the former is a specific type of the latter. Whereas undernutrition refers to an inadequate intake of specific nutrients, malnutrition covers both under and over-nutrition, such as obesity but also micronutrient deficiency. In the scope of micronutrient malnutrition, "malnutrition" generally refers to undernutrition and, thus, micronutrient deficiencies. Therefore, this paper will use the term 'micronutrient malnutrition' to define all vitamin and mineral deficiencies.
Despite an increasing number of local and global programs to control micronutrient malnutrition, especially the main micronutrient deficiencies (Vitamin A, iodine, zinc and iron) 6 , it remains a major public health problem, in particular for children and (pregnant)
women. According to global estimates of micronutrient malnutrition, nearly two billion people fail to achieve the recommended nutrient intake levels, mainly populations from lowincome countries 2 . As a consequence, an annual number of 10.3 billion US$ is still required to successfully fight the global burden of malnutrition, of which at least 1.5 billion US$ is needed to adequately combat micronutrient deficiencies 7 . Its magnitude differs when looking at specific micronutrient deficiencies and different data sources. The number of people with insufficient vitamin A intake, for example, varies between 140 8 , 190 9 and 254 million 8, 10 .
Iodine and zinc deficiency figures show that a total estimate of nearly 2 billion people is at risk 3, 11, 12 . Iron deficiency is another widespread type of micronutrient malnutrition, with 1.7 billion people below the recommended intake levels 3, 11 . However, the public health significance of a micronutrient deficiency must be evaluated by looking beyond its prevalence, i.e. by estimating its health impacts. and, indirectly, other major diseases (MDG 6), and to help achieve the goals on education (MDG 2) and gender equality (MDG 3) 11 .
[Insert Table 1 here]
III.
GM biofortification as a novel micronutrient intervention
There are currently four main strategies or (potential) policy interventions to address micronutrient malnutrition or particular vitamin or mineral deficiencies: pharmaceutical supplementation, food fortification, dietary diversification and biofortification (see Table 2 ).
Pharmaceutical supplementation refers to micronutrient programs that distribute (multi-) micronutrient supplements for free or which promote the use of supplements. Key supplementation programs are based upon iron, zinc, vitamin A and/or folic acid supplementation. The latter aims to reduce folate deficiency through increased consumption of folic acid, i.e. the synthetic form of folate. Industrial fortification refers to the insertion of micronutrients in staple crops, like rice and wheat, which takes place during flour milling.
Dietary diversification is considered the most sustainable intervention and is targeted towards an increased intake of micronutrient-rich foods through nutrition education, promotion of diverse diets, improved access to locally produced foods rich in vital micronutrients.
Although one could opt to address a particular micronutrient intervention through diversifying food habits, such as the promotion of green vegetables and citrus fruits to elevate folate intake levels, the ultimate goal of diversification strategies is usually to improve the dietary habits as whole, which encompasses a multi-micronutrient approach.
Biofortification is considered a novel strategy to combat the 'hidden hunger', by which the nutritional content of staple crops is enhanced. By sharing the advantages of fortification (e.g.
wide coverage) and addressing the limitations of supplementation (e.g. short term strategy, limited coverage, compliance of taking pills), it is intended to be a pro-rural and pro-poor health intervention (see Table 2 ). According to Welch 35 , agricultural approaches are a prerequisite to sustainably control micronutrient malnutrition. Biofortification is considered an agriculture/food based approach as it uses the regular food chain and goes beyond fortification, because the crops are fortifying themselves 36, 37 . This general definition of biofortification does not include agronomic biofortification, by which mineral contents are enhanced through the application of fertilizers 38 . Other biofortification strategies focus on the factors that increase the bioavailability of micronutrients rather than enhancing the production of micronutrients 39 . It is also important to note that also non-staple crops could be biofortified.
A more exhaustive overview of biofortified staple and non-staple products, including Table 2 presents an overview of the key characteristics of the different micronutrient interventions. The common objective of these interventions is primary prevention, i.e.
tackling micronutrient deficiencies as a risk factor of various diseases. While the two 'industry' based interventions, supplementation and food fortification, aim to reduce micronutrient malnutrition through the enhancement of micronutrient levels in, respectively, supplements (pharmaceutical industry) and staple crops (milling sector), the objective of dietary diversification and biofortification is to increase the natural micronutrient levels.
[Insert Table 2 here]
IV.
GM biofortification as a novel approach of crop improvement
Before biofortification, efforts to improve crop content were mainly focusing on agronomic traits, such as increasing yield potential and productivity, drought resistance and pest resistance, which primarily benefit the farmer. Table 3 gives an overview of the main stages of crop improvement. As these developments in agriculture were based on two different Gene revolutions meant for agricultural productivity and hunger (food quantity), these biofortification trend hopes to achieve in the field of malnutrition and the 'hidden hunger'
(food quality). In this respect, one can refer to a shift from producer, input or quantity traits to consumer, output or quality traits 66 . Although an increased micronutrient content is certainly one of the most advanced improved quality trait in crops, also other quality traits can be addressed, like the elimination of allergens, improved taste, texture or other sensory characteristics, and the prolongation of shelf life. Nevertheless, 'GM biofortified crops' and 'GM crops with health benefits' are treated as synonyms in this study.
Within the scope of crop improvement through GM technology, broadly two product categories can be distinguished: 1 st versus 2 nd generation GM products. GM biofortified crops belong to the 2 nd generation of GM crops, which are primarily designed to benefit the consumer by improving quality traits, among which nutritional properties. The application of GM technology to develop nutrient-dense crops is sometimes referred to as 'nutritional genomics' 67 . These developments followed the Gene Revolution and its 1 st generation of GM products, which dealt with enhanced agronomic traits, such as insect resistance and herbicide tolerance. In other words, the evolution from first to second generation involves a shift from producer-friendly to consumer-friendly genetic modification 68 . An overview of the consumer and farmer benefits of first and second generation GM food products is described in Toenniessen et al. 69 and Lönnerdal 70 , respectively.
Despite these 'generation' differences, future GM crops are more likely to combine improved traits from both the 1 st and 2 nd generation. In order to make GM biofortified crops attractive to consumers as well as producers, both the health and agronomic benefits have to be addressed. While farmers will be more in favor of adopting biofortified crops when the yield characteristics are beneficial 12, 71 , multi-biofortification will be more likely accepted and consumed by consumers. In this way, stacking refers to the improvement of different output and input traits.
Next to this tendency, some people argue the need for an 'evergreen' revolution, which combines the economic viability of the Green and/or Gene revolution with a need for ecological sustainability, while improving awareness and knowledge 72 . There is also a third generation of GM crops, where products are developed for industrial or pharmaceutical use.
Among the examples are vaccines or biodegradable plastics 73 .
[Insert Table 3 here]
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V.
The global status of (GM) biofortification and GM rice [Insert Table 4 here]
The current status and future pipeline of GM biofortified rice, i.e. GM rice with health benefits, is described in Table 5 and Since most of the GM rice product in the R&D pipeline are developed by Asian providers for direct use at the domestic market, the number of GM rice events that will be approved and [Insert Table 5 here]
[Insert Table 6 here]
VI. GM rice crop with health benefits: the case of rice biofortification
In order to successfully tackle micronutrient malnutrition through GM biofortification, one should carefully select the food vehicle for biofortification. In principle, a staple crop like rice, wheat, corn or potato should be selected in order to reach the rural, poor populations who need to increase their micronutrient intake levels the most. There are several reasons which underpin the focus on rice to reduce micronutrient malnutrition. Rice is not only the most consumed and produced product in the world. It is also known to have low micronutrient contents, such as folate and provitamin A. Furthermore, the selection of rice as the food vehicle for biofortification is in line with the technical considerations of fortification, i.e.
using an inexpensive, country-wide staple crop, as postulated by the Asian Development Bank 17, 87 .
In some cases, it is feasible to increase micronutrient concentrations in rice through conventional breeding techniques, similar to biofortified maize, wheat, beans, cassava 41 . This is, for example, true for zinc and iron levels in rice 88 . In other cases, however, the application of conventional plant breeding techniques to enhance the micronutrient content of rice is less may also be increased though transgenic approaches, and about 43 genes of five protein families are expected to be involved in rice 102 , they are not included in this study due to the lack of socio-economic studies on these GM biofortified rice crops. provitamin A in rice, the post-harvest losses (e.g. cooking) and the bioavailability, i.e. of the absorption of folate or provitamin A -converted into vitamin A -in the human body, vitamin concentrations after GM biofortification of rice vary between 1.5 µg -3.0 µg folate per g rice, and 1.0 µg -6.5 µg provitamin A per g rice, depending on the impact scenario. These micronutrient levels are substantially higher than in regular rice varieties. In the case of Folate Biofortified Rice, the total folate intake level after biofortification is 40 times larger than without biofortification. The amount of GM biofortified rice needed in order to recover from folate and vitamin A deficiency depends on the current rice consumption patterns, and whether these patterns are still maintained when (partially) switching to GM biofortified rice, and on the current (dietary) vitamin intake. The table below demonstrates how much GM biofortified rice a consumer needs to consume in order to achieve the daily recommended nutrient intake level (RNI) of the target group. This refers to a theoretical scenario where a consumer does not consume any vitamins through its diet. In other words, these figures represent the (GM biofortified) rice consumption threshold to avoid being micronutrient deficient in a situation where only rice could be consumed. In the current situation, i.e.
without folate biofortification, a consumer should eat about 5 kg of rice per day in order to reach the RNI for folate, if he/she only depends on rice. When the same consumer eats Folate Biofortified Rice instead, he/she only needs 281 g (pessimistic) to 137 g rice (optimistic) to achieve adequate folate levels. In the case of Golden Rice, it is even not possible to consume vitamin A through a regular rice diet. The two biofortification scenarios demonstrate that between 500 g and 77 g (children under 5 years) and 800 g -122 g golden rice (pregnant women) is daily needed to exceed the RNI for vitamin A. And even if the biofortified rice consumption should be below these theoretical thresholds, it should lead to positive health impacts, -although a full protection from the health outcomes of these micronutrient deficiencies is then impossible. Nevertheless, one could also argue that transgenic lines with a higher micronutrient content could be developed in order to tackle micronutrient deficiencies in regions with medium or low rice consumption. Storozhenko 81 , for example, reported transgenic rice lines with elevated folate levels up to 17 µg per g rice, as compared to an average of 12 µg folate per g rice.
[Insert Table 7 here]
The aforementioned GM biofortified crops are presented as examples of 'single trait' biofortification. However, a multi-biofortification approach might be more likely to occur in the future. Such biofortified crops with enhanced micronutrient concentrations can be developed in two ways. In the so-called 'single insertion' approach, the targeted micronutrient traits are stacked as one gene construct. A 'backcrossing' approach, where all traits are separately developed and combined through backcrossing 81, 93 , is expected to be more costly, due to high regulatory and financial costs to approve all new events as single traits, as well as the time and financial costs required for the testing and approval of each event 111 . Moreover, micronutrient traits are mainly developed by different research institutes, which makes a single insertion approach the most realistic scenario.
VII. Published research coverage on GM food, GM rice, biofortification and Golden Rice
This section gives a brief overview of the number of publications (2000-2011) in four relevant research domains: GM food, GM rice, biofortification, and Golden Rice. Whereas GM food and (GM or conventional) biofortification are broad food research topics, the topics GM rice and particularly Golden Rice deal with research applied on a specific staple crop. In this way, this exercise aims to summarize the evolution of international peer-reviewed journal publications in these different, but closely related research fields and particularly in the domain of GM rice crops with health benefits. Golden Rice was selected as it is the GM biofortified crop that received most attention, both at research and policy level.
This rudimentary, targeted trend analysis is based on a literature search in the electronic literature database Web of Knowledge. The database search used the following keywords in the topic field: GM food; GM rice; biofortification and Golden Rice. It is important to notice that the selection of publications is based on studies from various research disciplines, like biotechnology and genetic engineering (e.g. R&D), agriculture (e.g. impact analyses), politics (e.g. policy level analysis), marketing (e.g. consumer studies), economics (e.g. costeffectiveness assessment), and so on. Furthermore, some of the selected studies, for example, did not focus on Golden Rice alone but included it as a case-study, a benchmark exercise or referred to, or built upon this application as a part of the study. Therefore, the extent to which these studies actually explore GM food or another topic (keyword) varies substantially, by which the total numbers should be interpreted with caution. Nevertheless, as this potential selection bias occurs in each database search, it is possible to benchmark the importance of these GM related fields in scientific literature. Stated differently, one should evaluate the trends, rather than the absolute figures.
The results in Figure 1 show that the number of publications in all four research domains [Insert Figure 1 here]
VIII. Consumer preferences for GM biofortified rice
As none of the GM biofortified crops are currently approved for cultivation and consumption, it is crucial to determine ex-ante the potential demand for such novel crops. Within the large body of literature on biofortification and GM food/rice, there are several studies that aimed to determine consumers' willingness-to-pay for GM biofortified rice. Given the direct health benefits associated with GM biofortification, due to the enhanced micronutrient content, these studies mainly aimed to assess the amount consumers are willing to pay more for nutritionally enriched rice. In Table 8 118 , for example, are partly due to the high prevalence rate of vitamin A deficiency in this region. Also De Groote et al. 119 elicited valuations for a crop with a higher vitamin content, namely willingness-to-pay for biofortified corn. Their results showed that consumers in Kenya are prepared to pay 24 % more for corn if it would be enriched with provitamin A. Although these findings provide insight in the consumer preferences for GM biofortified rice, caution is needed when benchmarking these premiums, due to the study specific characteristics (e.g. the valuation method, the sample selection, the targeted product and the selected trait). Nevertheless, when looking at the high premiums, these positive reactions support the high potential demand for GM biofortified crops.
[Insert Table 8 here]
IX. Potential cost-effectiveness of GM biofortified rice
As GM biofortified rice is not only an innovative food crop, which is based on agricultural biotechnology, but also a potential alternative policy intervention to reduce the burden of micronutrient malnutrition, health impact and cost-effectiveness analyses are also considered a crucial aspect to adequately evaluate its socio-economic potential 120 . In Table 9 five key health impact studies are described, of which four also assessed the potential health impact.
The Chinese regional health impact analysis of De Steur et al. 27 is not included, as the study on multi-biofortification further builds upon their results by including a cost-effectiveness study on folate and three other micronutrient traits in rice (provitamin A, zinc and iron). For an overview of cost-effectiveness studies on other biofortified crops, see Meenakshi et al. 121 .
The potential health benefits of folate, provitamin A and multi-biofortified rice are measured by their potential contribution to lower the current burden of micronutrient deficiencies. The results vary between 6 % and 20 % in the pessimistic scenario and 32 % and 60 % in the optimistic scenario. The cost-effectiveness is expressed by the cost (US$) to save a DisabilityAdjusted Life Year (DALY) that is initially lost due to the targeted micronutrient deficiency.
When looking at the World Bank cost-effectiveness cut-off level for highly cost-effective health interventions 122 , i.e. 258 US$ per DALY saved in 2011 123 , all GM biofortified rice crops fall below this threshold. Due to the combined health impacts multi-biofortified rice, and the associated cost reductions, the cost-effectiveness of this GM rice crop is substantially lower than the so-called single GM biofortified rice crops.
Although these studies differ in its targeted trait and country, but also in the data assumptions, this table is not intended for comparison of different figures. Instead, one should interpret the evaluation of the introduction of the different GM biofortified rice crops as a whole. Taken together the health impact and cost-effectiveness figures, GM biofortified rice, regardless of the targeted trait or region, is considered a highly cost-effective intervention to combat micronutrient malnutrition.
[Insert Table 9 here]
X.
Key challenges of the commercialization of GM biofortified rice
Despite its large potential, GM biofortification has not been the magic bullet in the fight against micronutrient deficiencies. According to Hotz and McClaferty 124 there are numerous, technical, practical, market oriented or other concerns that need be addressed to successfully achieve the goal of biofortifying staple crops. For instance, although some target micronutrients need to undergo bioconversion before the body can utilize them, a process that is not 100% effective e.g. pro-vitamin A (beta-carotene) needs to be converted to vitamin A.
Furthermore, although differences in appearance could be used to adequately position biofortified products in the market place 41 , several studies show that acceptance of GM crops will be compromised if they do not resemble the conventional products [125] [126] [127] . Rice fortification, for instance, may lead to an intensification of color, which negatively affected its acceptability in Thailand and Bangladesh 128 . With respect to Golden Rice, the visible differences between this GM biofortified rice crop and its regular counterpart could be a constraint to consumer acceptance, because its yellow color may be linked with a longer shelf life and, thus, lower quality. Similarly, orange, pro-vitamin A biofortified maize is less preferred than unfortified white maize 129, 130 .
Although scientific evidence is lacking, GM biofortification may also change sensory attributes, which could reduce consumers' willingness to consume such micronutrient enriched crops. The aroma and taste of (conventional) pro-vitamin A enriched maize, for example, was negatively evaluated in Mozambique 130 . Other negative product attribute changes that might be associated with GM biofortification of rice, such as shelf life, duration and sensory quality of cooking, could also play a role and need to be further investigated 129 .
For a discussion on key issues and challenges to advance towards a successful implementation of Folate Biofortified Rice and Golden Rice, we refer to De Steur et al. 120 and the Bertebos foundation report 131 , respectively.
XI. Conclusions
GM biofortified rice as a specific GM crop with health benefits is more and more examined as an alternative policy intervention to combat micronutrient malnutrition. At the turn of the century, the first publications on biofortification and Golden Rice as the first GM biofortified crop appeared. From 2004 onwards, the amount of research in the field of GM food, GM rice and particularly biofortification drastically increased. When looking at consumer studies on GM biofortified rice, the findings show that consumers in target countries are willing to pay for improved micronutrient contents in rice. The high premiums for both Folate Biofortified
Rice and Golden Rice, indicate that there is a consumer market for GM rice crops with health benefits. The high cost-effectiveness of single (folate, provitamin A) and multi-biofortified rice (folate, provitamin A, zinc and iron) further support the potential of GM biofortification to tackle a major public health problem like vitamin A and folate deficiency.
GM biofortification of rice comes at a time when the debate is rife on the adoption of GM food in many countries in the developing world. Despite its additional health benefits, future research is needed to adequately and sustainably introduce GM biofortified rice at the market place. Even though pro-vitamin A enriched rice is on the verge of being released, it is evident that it will only serve regions where rice is a staple. Moreover, although GM biofortification 81 . a The human body converts beta-carotene or provitamin A into vitamin A; b Niancin or Vitamin B3 is an essential nutrient which is mainly lacking in maize consuming populations 82 . Niancin is available in different foods, but can also be made in the human body through tryptophan, i.e. an amino acid that is improved by biofortification; c These are the selected countries where the biofortified crops are released or expected to be tested and released. However, after the first release, these crops are intended to benefit also other countries characterized by similar micronutrient deficiencies; d Because these crops are still in a development phase, it is too early to select a target country and a release date. Here, China was selected due to its high folate deficiency prevalence rates, its recent approval of Bt rice and the potential high impact of the introduction of Folate Biofortified Rice 14 ; e Although the transgenic Golden Rice was expected to be released in 2011 83 , field tests and biosafety regulations are still ongoing in the Philippines. The GR trait was also bred into rice varieties in, for example, India, Vietnam, Bangladesh and Indonesia. (2012) were not included as they were incomplete at the time of the study.
